Certain Cancer Drug Elevates the Risk of Heart Failure
The risk of heart failure is alarmingly high in older women with breast cancer. And, according to Yale University researchers, if those women take one commonly prescribed drug, the risk is even higher.
The health warning targets “adjuvant trastuzumab,” which goes by the brand name “Herceptin.” It is used for breast tumors linked to the “HER-2 factor,” a term familiar only to those who’ve dealt with it. Basically, it’s a protein that seems to have a causal role in breast cancer.